Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP115381.RAXMZlVooHs8q-PYSctI-4BUwSLeS30DQhjs1V54Jx9w0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP115381.RAXMZlVooHs8q-PYSctI-4BUwSLeS30DQhjs1V54Jx9w0130_assertion type Assertion NP115381.RAXMZlVooHs8q-PYSctI-4BUwSLeS30DQhjs1V54Jx9w0130_head.
- NP115381.RAXMZlVooHs8q-PYSctI-4BUwSLeS30DQhjs1V54Jx9w0130_assertion description "[Ovarian cancer patients with high ERCC1 expression or the C/C genotype at codon 118 may benefit from the combination of platinum and paclitaxel, while those with low ERCC1 expression or the C/T or T/T genotype may respond well to platinum without paclitaxel.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP115381.RAXMZlVooHs8q-PYSctI-4BUwSLeS30DQhjs1V54Jx9w0130_provenance.
- NP115381.RAXMZlVooHs8q-PYSctI-4BUwSLeS30DQhjs1V54Jx9w0130_assertion evidence source_evidence_literature NP115381.RAXMZlVooHs8q-PYSctI-4BUwSLeS30DQhjs1V54Jx9w0130_provenance.
- NP115381.RAXMZlVooHs8q-PYSctI-4BUwSLeS30DQhjs1V54Jx9w0130_assertion SIO_000772 18024864 NP115381.RAXMZlVooHs8q-PYSctI-4BUwSLeS30DQhjs1V54Jx9w0130_provenance.
- NP115381.RAXMZlVooHs8q-PYSctI-4BUwSLeS30DQhjs1V54Jx9w0130_assertion wasDerivedFrom gad-20150221 NP115381.RAXMZlVooHs8q-PYSctI-4BUwSLeS30DQhjs1V54Jx9w0130_provenance.
- NP115381.RAXMZlVooHs8q-PYSctI-4BUwSLeS30DQhjs1V54Jx9w0130_assertion wasGeneratedBy ECO_0000203 NP115381.RAXMZlVooHs8q-PYSctI-4BUwSLeS30DQhjs1V54Jx9w0130_provenance.